26 April 2016 : Clinical Research
Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37
DOI: 10.12659/MSM.895971
Med Sci Monit 2016; 22:1398-1402
HTML version available soon